Intravenous Magnesium: Prompt Use for Asthma in Children Treated in the Emergency Department (IMPACT-ED)

← Back to all studies

Intravenous Magnesium: Prompt Use for Asthma in Children Treated in the Emergency Department (IMPACT-ED)

Health Condition: Asthma
Health Impact Domain: Safety of care, Effectiveness of care, Timeliness of care, Decreased incidence/length of hospitalization

Summary

This pilot trial is a first step to determine if a simple and inexpensive medicine, intravenous magnesium sulfate (IV Mg), can improve outcomes of children treated in emergency departments for severe acute asthma. This pilot trial will enroll 90 children across three hospitals and evaluate giving IVMg or placebo early in ED treatment when the impact on hospitalization would be greatest, characterize changes in blood pressure when IV Mg is given, and collect information necessary to understand what dose of IV Mg is likely to be most effective.

Key Publications

Related Media

-

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of the Emergency Medical Services for Children Data Center award totaling $3,200,000 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.